LATE-LIFE DEPRESSION ACCELERATES COGNITIVE DECLINE IN A TAUOPATHY MOUSE MODEL

LATE-LIFE DEPRESSION ACCELERATES COGNITIVE DECLINE IN A TAUOPATHY MOUSE MODEL

Bibliographic Details
Main Authors:	Laura Vegas-Gomez, Juan Jose Fernandez-Valenzuela, Antonia Gutierrez, Inés Moreno-González
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123010679

Similar Items

Common mouse models of tauopathy reflect early but not late human disease
by: Kathrin Wenger, et al.
Published: (2023-02-01)

CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy
by: Min Sung Gee, et al.
Published: (2024-04-01)

Editorial: Prevention and treatment of depression and subjective cognitive decline in late life: the role of lifestyles
by: Wei Liang, et al.
Published: (2023-11-01)

Knock-out and transgenic mouse models of tauopathies.
by: Denk, F, et al.
Published: (2009)

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
by: Yuriko Nakaoku, et al.
Published: (2019-05-01)

Using mass spectrometry to validate mouse models of tauopathy
by: Yan Yan, et al.
Published: (2023-04-01)

Novel autoimmune response in a tauopathy mouse model
by: Carlos J Nogueras-Ortiz, et al.
Published: (2014-01-01)

Tauopathy and cognitive impairment in experimental diabetes mellitus
by: Mariia V. Matveeva, et al.
Published: (2017-08-01)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
by: Jamal B. Williams, et al.
Published: (2023-01-01)

Effects of Radix Polygalae on Cognitive Decline and Depression in Estradiol Depletion Mouse Model of Menopause
by: Gaeul Han, et al.
Published: (2021-10-01)

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
by: Snehajyoti Chatterjee, et al.
Published: (2018-11-01)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
by: Naruhiko Sahara, et al.
Published: (2023-04-01)

PINK1 Alleviates Cognitive Impairments via Attenuating Pathological Tau Aggregation in a Mouse Model of Tauopathy
by: Xing Jun Jiang, et al.
Published: (2022-01-01)

Subjective cognitive decline and cerebral-cognitive reserve in late age
by: Alena Sidenkova, et al.
Published: (2023-01-01)

Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy
by: François Ruch, et al.
Published: (2024-02-01)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
by: L. Arouche-Delaperche, et al.
Published: (2023-01-01)

Synergistic associations of depressive symptoms and aging on cognitive decline in early Parkinson’s disease
by: Lea Hemphill, et al.
Published: (2023-01-01)

Rural residence across the life course and late‐life cognitive decline in KHANDLE: A causal inference study
by: Rachel L. Peterson, et al.
Published: (2023-01-01)

Heparan Sulfate Proteoglycans in Tauopathy
by: Yanan Zhu, et al.
Published: (2022-11-01)

Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy
by: Thomas Ridler, et al.
Published: (2020-11-01)

Clinical Spectrum of Tauopathies
by: Nahid Olfati, et al.
Published: (2022-07-01)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
by: Marta del Campo, et al.
Published: (2021-10-01)

Identification of gene networks mediating regional resistance to tauopathy in late-onset Alzheimer's disease.
by: Christopher A Ayoub, et al.
Published: (2023-03-01)

Age‐related cognitive decline is accelerated in alcohol use disorder
by: Kazuhiro Kurihara, et al.
Published: (2023-12-01)

The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy
by: Joshua Yang, et al.
Published: (2023-04-01)

Correction: Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy
by: Thomas Ridler, et al.
Published: (2023-03-01)

Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy
by: Marta Anglada-Huguet, et al.
Published: (2023-05-01)

The effect of depression on cognitive decline among Korean retirees
by: In Cheol Hwang, et al.
Published: (2023-01-01)

Hemimegalencephaly: A Foetal Tauopathy
by: J Gordon Millichap
Published: (2013-02-01)

Differential vulnerability of the dentate gyrus to tauopathies in dementias
by: Allegra Kawles, et al.
Published: (2023-01-01)

Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life.
by: Christina Ting, et al.
Published: (2010-04-01)

Epidemiology of late life depression
by: ra Schoevers
Published: (2024-02-01)

The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy
by: Lanxia Meng, et al.
Published: (2023-11-01)

Comparative characteristics of enzymatic antioxidant protection in patients with mild cognitive decline and late-onset depression. Is a therapeutic correction possible?
by: N. M. Zalutskaya, et al.
Published: (2018-07-01)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
by: Rachel Keszycki, et al.
Published: (2023-06-01)

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
by: Raquel Sanchez-Varo, et al.
Published: (2022-05-01)

Nasal administration of mesenchymal stem cells prevents accelerated age-related tauopathy after chemotherapy in mice
by: Miriam Zamorano, et al.
Published: (2023-01-01)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
by: Geraldine Zimmer-Bensch, et al.
Published: (2021-11-01)

Electric field distribution predicts efficacy of accelerated intermittent theta burst stimulation for late-life depression
by: Davin K. Quinn, et al.
Published: (2023-08-01)

Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies
by: Benjamin Chun-Kit Tong, et al.
Published: (2022-10-01)